Topic: Ulcerative Colitis.
Destination: The principal aim of this grant program is to support global research that advances the role of Sphingosine-1-phosphate (S1P) receptor modulation in the treatment of Ulcerative Colitis (UC).
Budget: $600,000 USD.
Duration: 18 months.
Fill out the form below to receive more information: